Gene Editing Market

Merck KGaA (Germany) and Thermo Fisher Scientific, Inc. (US) are Leading Players in the Gene Editing Market

The gene editing market is projected to grow from USD 5.3 billion in 2023 to USD 10.6 billion by 2028 at a CAGR of 15.0%. Gene editing or genome engineering is the insertion, deletion, or replacement of DNA at a specific site in the genome of an organism or cell. It is usually achieved in the lab using genome-editing tools, such as CRISPR, TALEN, and ZFN. This emerging and rapidly evolving field enables the efficient and directed modification of cell lines and genomes of animals and plants.

The global gene editing market is highly fragmented, with prominent players such as Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (US), GenScript (China), Agilent Technologies (US), PerkinElmer (US), Lonza (Switzerland), Tecan Life Sciences (Switzerland), Sangamo Therapeutics (US), Editas Medicine (US), CRISPR Therapeutics AG (Switzerland), Precision Biosciences (US), Cellectis S.A. (France), Intellia Therapeutics (US), Bluebird Bio, Inc. (US), Regeneron Pharmaceuticals (US), AMSBIO (England), Creative Biogene (US), Synthego Corporation (US), and Beam Therapeutics Inc. (US). Others include Caribou Biosciences, Inc. (US), OriGene Technologies (US), New England Biolabs (US), Inscripta (US), and Mammoth Biosciences (US).

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific (US) offers a complete and integrated portfolio of solutions and services for clinical science, laboratory research, and analysis. Thermo Fisher Scientific has built a diverse portfolio suitable for gene modification and precision genome editing. High-efficiency delivery systems provided by the company help develop gene expression systems, modified genes, and stable engineered cell lines, contributing to Thermo Fisher’s presence in the gene editing market. Additionally, the company’s genome editing technologies are accessible through licensing in various commercial applications, including contract manufacturing services, research, vaccine development & manufacturing, animal health, biofuels, and diagnostics. These gene editing technologies/products include CRISPR-Cas9 and TAL effectors.

Merck KGaA (Germany) is among the top three companies operating in the gene editing market. The company works closely with pharmaceutical and biotechnology companies engaged in genomic and personalized medicine. Licensing its proprietary editing technology to these companies has strengthened its market position. In March 2022, the company signed a collaboration and license agreement with BetterSeeds, an Israeli company engaged in developing new breeds of plants using CRISPR. This license agreement was made through Merck’s Life Science division, MilliporeSigma, and is targeted toward expanding the reach of this proprietary technology. The Life Science business of Merck holds 28 CRISPR-related patents worldwide in methods and composition, including the foundational technology of CRISPR Cas9 for genetic integration in mammalian cells.

GenScript (China) is a prominent player in the gene editing market, with a comprehensive portfolio of products and services for gene editing. The company offers validated CRISPR products, services, and resources through its partnership with Feng Zhang’s laboratory at the Broad Institute of MIT and Harvard. GenScript’s expertise in CRISPR technology results from robust R&D investments and flexible solutions applicable across cell therapy, CAR-T cell therapy, and gene therapy applications. GenScript has emerged as a strong competitor to the top market players in the past few years.

Related Reports:

Gene Editing Market by Product & Service (Reagents, Consumables, Systems, Software), Technology (CRISPR, TALEN, ZFN, Antisense), Application (Cell Line Engineering, Genetic Engineering, Drug Discovery), End User (Pharma, Biotech) – Global Forecast to 2028

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Gene Editing Market Size,  Share & Growth Report
Report Code
BT 3380
RI Published ON
Choose License Type

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
©2024 MarketsandMarkets Research Private Ltd. All rights reserved Protection Status